Evidence map›Paper›PMID 34200041›Full record

ArticleMicroorganisms2021

Probiotic Potential and Cholesterol-Lowering Capabilities of Bacterial Strains Isolated from

Qianxian He, Jingyu Li, Yongkai Ma, Qi Chen, Gu Chen

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Complete genome sequence ofMicrobiology resource announcements · 2025
    Article
  7. Complete genome sequence ofMicrobiology resource announcements · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Frontiers in microbiology · 2023
    Article
  12. Safety Assessment of OneFoods (Basel, Switzerland) · 2022
    Article
  13. Potential application of the probioticFrontiers in microbiology · 2022
    Review
  14. Causal relationship between gut microbes and cardiovascular protein expression.Frontiers in cellular and infection microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Qianxian HeSchool of Food Science and Engineering, South China University of Technology, Guangzhou 510640, China.
Jingyu LiSchool of Food Science and Engineering, South China University of Technology, Guangzhou 510640, China.
Yongkai MaSchool of Food Science and Engineering, South China University of Technology, Guangzhou 510640, China.
Qi ChenSchool of Food Science and Engineering, South China University of Technology, Guangzhou 510640, China.
Gu ChenSchool of Food Science and Engineering, South China University of Technology, Guangzhou 510640, China.ORCID 0000-0002-2221-8006
South China University of Technology · CN

Funding

National Natural Science Foundation of China Grant No. 31871766Natural Science Foundation of Guangdong Province, China No. 2018A030313783Science and Technology Program of Guangdong Province, China No.2015A020209029Science and Technology Program of Guangzhou, China No. 202002030051
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bacilluscholesterol-lowering potentialLactobacillusPericarpium Citri Reticulatae ‘Chachiensis’probiotic bacteria

Identifiers

PMID34200041
PMCPMC8227569
OpenAlexW3172658817

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.